Sanofi India Limited engages in the manufacture and distribution of pharmaceutical drugs. The firm offers its products under the following brands: AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Amaryl, Renvela Sachets, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trenta, Vinlep, and Zolineg. It also focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines. The company was founded on May 2, 1956 and is headquartered in Mumbai, India.

sanofi india limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. sanofi india limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE058A01010
Equity Stock (National Stock Exchange) Symbol: SANOFI
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SANOFI
BSE Link IS: https://www.bseindia.com/stock-share-price/sanofi-india-ltd/SANOFI/500674/

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.

India – Branded generics (79% of CY20 revenues):[1] Top-7 brands contribute ~70% of domestic sales and are growing at high single digits.

IN

Sanofi India Ltd stand with []

Company Website: http://www.sanofiindialtd.com/
Company Website2: http://www.sanofiindialtd.com/
LinkedIn page URL: https://in.linkedin.com/company/sanofi-india-ltd
Wiki Profile URL:

Popular Search Keywords: sanofi india limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#sanofi #india #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Sanofi India Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Glenmark Life Sciences Limited engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

glenmark life sciences limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. glenmark life sciences limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE03Q201024
Equity Stock (National Stock Exchange) Symbol: GLS
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=GLS
BSE Link IS: https://www.bseindia.com/stock-share-price/glenmark-life-sciences-ltd/GLS/543322/

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.

A subsidiary of Glenmark Pharmaceuticals[1] Glenmark Life Sciences (GLS) is a subsidiary of Glenmark Pharmaceuticals Ltd which launched the API business by setting up a manufacturing facility in 2001 to cater to the growth in the API segment across the world and in 2019, the API manufacturing business of Glenmark was spun off into GLS, which will act as an independent company and focus on API business

Glenmark Life Sciences (GLS) develops and manufactures a range of high-quality, industry-leading Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Leveraging our state-of-the-art laboratories and manufacturing locations, we supply over 130 molecules to more than 700 customers, which include the world’s top 20 generic companies. From product selection & development to commercialization, we judiciously blend science, technology and economics to stay ahead of the curve. Our culture of environmental stewardship, responsible business practices and operational excellence makes us one of the most reliable and preferred partner in the industry. Our track record of regulatory compliance, cost advantage, speed and superior quality ensures business continuity for our customers spread over 65 countries, being one of the fastest growing API companies in the industry. Our revenue, historically generated from US and Europe, is rapidly expanding to new Emerging Geographies like South East Asia, Russia, Middle East, Japan and Latin America.

Our people are our key differentiator. Our knowledgeable, responsible and inspired team, of over 1400 colleagues from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. For GLS employees, business is about relationships, hence we work as partners, who intend to preempt, meet and even exceed customer expectations.

At GLS, we embrace an approach to business that lays equal amount of emphasis on generating value for the economy, environment and the society.

GLS (www.glenmarklifesciences.com) was incorporated as an independent subsidiary of Glenmark Pharmaceuticals on January 1, 2019, to provide a strategic focus to the API business and help it unleash its full potential. Glenmark Pharmaceuticals (www.glenmarkpharma.com) is a 40 year-old integrated, research-driven, global pharmaceutical organization committed to enriching lives.

Glenmark Life Sciences stand with [Passion. Innovation. Partnership]

Company Website: http://www.glenmarklifesciences.com/
Company Website2: http://www.glenmarklifesciences.com/
LinkedIn page URL: https://in.linkedin.com/company/glenmark-life-sciences
Wiki Profile URL:

Popular Search Keywords: glenmark life sciences limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#glenmark #life #sciences #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Glenmark Life Sciences Limited – Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Sun Pharmaceutical Industries Limited engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.

sun pharmaceutical industries limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. sun pharmaceutical industries limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE044A01036
Equity Stock (National Stock Exchange) Symbol: SUNPHARMA
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SUNPHARMA
BSE Link IS: https://www.bseindia.com/stock-share-price/sun-pharmaceuticals-industries-ltd/SUNPHARMA/524715/

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.

Product Offerings The company produces a comprehensive and diverse portfolio of generic and specialty medicines targeting wide spectrum of chronic and acute treatments. Its product portfolio includes generics, branded generics, specialty, difficult-to-make technology intensive products, anti-retrovirals, APIs and intermediates. It offers medicines in all form of dosages i.e. injectables, sprays, ointments, creams, liquids, tablets and capsules.

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma’s global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues.

See our community guideline: bit.ly/2WYiDZ5

SUN PHARMA stand with [Reaching People. Touching Lives.]

Company Website: http://www.sunpharma.com/
Company Website2: http://www.sunpharma.com/
LinkedIn page URL: https://in.linkedin.com/company/sun-pharma
Wiki Profile URL: https://en.wikipedia.org/wiki/Sun_Pharma

Popular Search Keywords: sun pharmaceutical industries limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#sun #pharmaceutical #industries #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Sun Pharmaceutical Industries Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Pfizer Limited engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm’s products include Prevenar 13, Lyrica, Ativan, Viagra, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Amlogard, Trulimax, Daxid, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, Corex Range, Anacin, and Anne French. The firm operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.

pfizer limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. pfizer limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE182A01018
Equity Stock (National Stock Exchange) Symbol: PFIZER
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=PFIZER
BSE Link IS: https://www.bseindia.com/stock-share-price/pfizer-ltd/PFIZER/500680/

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.

Product Portfolio Presently, the company sells ~150 different products across 15+ therapeutic areas viz. anti-allergic, anti-diabetic, anti-infectives, cardiovascular, gastrointestinal, neurology, pain, respiratory, vitamin/minerals, antibiotics, etc.

Breakthroughs That Change Patients’ Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.To learn more, visit www.pfizer.com.

For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

Beware of scams from individuals, organizations and Internet sites claiming to represent Pfizer in recruitment activities. A formal Pfizer recruitment process is required for all authorized positions posted by Pfizer prior to issuing an offer of employment. This Pfizer process includes an interview and never requires payment or fees from job applicants. If you receive a suspicious email message or phone call about recruiting on behalf of Pfizer, do not provide any personal information or pay any fees. Interested candidates should apply to current openings through this Pfizer website. Pfizer accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.

Pfizer stand with [Breakthroughs that change patients’ lives]

Company Website: http://www.pfizer.com/
Company Website2: http://www.pfizerindia.com/
LinkedIn page URL: https://in.linkedin.com/company/pfizer
Wiki Profile URL:

Popular Search Keywords: pfizer limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#pfizer #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Pfizer Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Ipca Laboratories Limited engages in the manufacture, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

ipca laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. ipca laboratories limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE571A01020
Equity Stock (National Stock Exchange) Symbol: IPCALAB
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=IPCALAB
BSE Link IS: https://www.bseindia.com/stock-share-price/ipca-laboratories-ltd/IPCALAB/524494/

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

History: [1] Ipca Laboratories Limited is a pharmaceutical company incorporated in 1949. The company was promoted by a group of medical professionals and businessmen and was incorporated under the name

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949.

When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.

Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

– One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally – 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis – Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy – 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Ipca Laboratories Limited stand with [A dose of life]

Company Website: https://www.ipca.com/
Company Website2: http://www.ipca.com/
LinkedIn page URL: https://in.linkedin.com/company/ipca
Wiki Profile URL: https://en.wikipedia.org/wiki/Ipca_Laboratories

Popular Search Keywords: ipca laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#ipca #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Ipca Laboratories Limited Company Profile | KooCapital.Com appeared first on KooCapital.Com.

Biocon Limited is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

biocon limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. biocon limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE376G01013
Equity Stock (National Stock Exchange) Symbol: BIOCON
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=BIOCON
BSE Link IS: https://www.bseindia.com/stock-share-price/biocon-ltd/BIOCON/532523/

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Biologics (31% of sales)
Has one of the largest biosimilar pipelines comprising 28 molecules to be launched over the next decade.

Biocon: Enhancing Global Healthcare

Biocon Limited, publicly listed in 2004, is India’s largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high.

The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars.

The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products.

We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders.

Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five’ people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years.

We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets.

We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin.

Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector.

Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster’ drugs with the potential to benefit a billion patients.

Biocon stand with slogan [Delivering Affordable Innovation.]

Company Website: http://www.biocon.com/
Company Website2: http://www.biocon.com/
LinkedIn page URL: https://in.linkedin.com/company/biocon
Wiki Profile URL: https://en.wikipedia.org/wiki/Biocon

Popular Search Keywords: biocon limited, company management, company history, company profile, company information, business directory, Stock Market News, annual report, quarterly results, profit and loss, Koo Capital, KooCapital.Com, KooCapital News, Health Technology Sector Company, Pharmaceuticals: Major industry

#biocon #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Biocon Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.

Gland Pharma Limited manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. It carries out its operations through the following geographic segments: USA, India, Europe, Canada, Australia, and Rest of World. The company was founded by P. V. N. Raju in 1978 and is headquartered in Hyderabad, India.

gland pharma limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. gland pharma limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE068V01023
Equity Stock (National Stock Exchange) Symbol: GLAND
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=GLAND
BSE Link IS: https://www.bseindia.com/stock-share-price/gland-pharma-ltd/GLAND/543245/

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Revenue breakup
GLand Pharma is primarily a contract manufacturer of injectables, with B2B segment generating 96% of revenues in FY20
US accounted for 71% of revenues in FY20 whereas India accounted for 18.50% of revenues in FY20
Within India, Gland has a sales force of 200 people serving B2C market

Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.

Gland Pharma Limited stand with slogan [Ethics, Excellence and Efficacy]

Company Website: http://www.glandpharma.com/
Company Website2: http://www.glandpharma.com/
LinkedIn page URL: https://in.linkedin.com/company/gland-pharma-limited
Wiki Profile URL:

Popular Search Keywords: gland pharma limited, company management, company history, company profile, company information, business directory,Stock Market News, annual report, quarterly results, profit and loss, Koo Capital, KooCapital.Com, KooCapital News, Health Technology Sector Company, Pharmaceuticals: Major industry

#gland #pharma #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry

The post Gland Pharma Limited – Company Profile – Company information | KooCapital.Com appeared first on KooCapital.Com.